Cover Image
Market Research Report
Product code 
1063031

Insulin Delivery Devices Market: Current Analysis and Forecast (2021-2027)

Published: | UnivDatos Market Insights Pvt Ltd | 227 Pages | Delivery time: 1-2 business days

Price

Back to Top
Insulin Delivery Devices Market: Current Analysis and Forecast (2021-2027)
Published: February 1, 2022
UnivDatos Market Insights Pvt Ltd
Content info: 227 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Insulin Delivery Devices Market is expected to grow at a CAGR of around 10% over the forecast period (2021-2027). The rise of this market is fueled by a growing diabetic population, obesity, and a sedentary lifestyle. Furthermore, advancements in human insulin delivery systems, innovations in insulin delivery system techniques, and healthy reimbursement policies, as well as rising awareness among the population about diabetes control and accessibility to insulin delivery systems, are all factors ensuring the market's growth.

Several government organizations are focusing on boosting the existing infrastructure for overall healthcare system development. Among the countries worldwide, the United States had the highest percentage of gross domestic product spent on health care in 2019. The U.S. spent nearly 17% of its GDP on health care services. Germany, Switzerland, and France followed the U.S. with distinctly smaller percentages. The United States had both significantly higher private and public spending on health compared with other developed countries.

The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.

Some of the major players operating in the market include: Medtronic, Becton, Dickinson and Company, Novo Nordisk, Eli Lilly and Company, Sanofi, Insulet Corporation, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Animas Corporation, Biocon Ltd, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.

Insights Presented in the Report

"Amongst Type, Insulin Pens segment dominated the market in 2020"

Based on Type, the market is segmented into Insulin Pens (Reusable, Disposable), Insulin Pumps (External, Tethered, Patch), Insulin Syringes, Insulin Jet Injectors and Other Devices. The Insulin Pens segment leads the Insulin Delivery Devices Market. Insulin pens are growing in popularity, and many people with diabetes nowadays use a pen to administer insulin as it allows more simple, accurate, and convenient delivery than using a vial and syringe.

"Amongst End-User, Patients/Homecare segment dominated the market in 2020."

Based on End-User, the Insulin Delivery Devices market is segmented into Patients/Homecare and Hospitals & Clinics. The patients/homecare segment commanded the largest share of the insulin delivery devices market and is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing diabetic population and rising healthcare expenditure.

"North America represents as the largest market."

For a better understanding of the market adoption of Insulin Delivery Devices, the market is analyzed for the countries such as North America (US, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia- Pacific), & Rest of World. Asia-Pacific dominated the market in 2020. North America dominated the market. The rising prevalence of diabetes and favorable reimbursement scenario in the United States and Canada, growing venture capital investments and IPOs in the United States, and FDA approvals to increase the commercial availability of insulin delivery devices in the United States all contribute to this region's large share.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional & country-level analysis of the industry

Customization Options:

Insulin Delivery Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Product Code: UMHE21665

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stake Holders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Insulin Delivery Devices Market
  • 2.2. Research Methodology of the Insulin Delivery Devices Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Insulin Delivery Devices Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 INSULIN DELIVERY DEVICES MARKET COVID-19 IMPACT

6 INSULIN DELIVERY DEVICES MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Insulin Pens
    • 7.1.1. Reusable
    • 7.1.2. Disposable
  • 7.2. Insulin Pumps
    • 7.2.1. External
    • 7.2.2. Tethered
    • 7.2.3. Patch
  • 7.3. Insulin Syringes
  • 7.4. Insulin Jet Injectors
  • 7.5. Other Devices

8 MARKET INSIGHTS BY END-USER

  • 8.1. Patients/Homecare
  • 8.2. Hospitals & Clinics

9 MARKET INSIGHTS BY REGION

  • 9.1. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. EUROPE INSULIN DELIVERY DEVICES MARKET
    • 9.2.1. Germany
    • 9.2.2. France
    • 9.2.3. United Kingdom
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. Rest of Asia Pacific
  • 9.4. REST OF WORLD INSULIN DELIVERY DEVICES MARKET

10 INSULIN DELIVERY DEVICES MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 INSULIN DELIVERY DEVICES MARKET OPPORTUNITIES

12 INSULIN DELIVERY DEVICES MARKET TRENDS

13 INSULIN DELIVERY DEVICES & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. COMPETITIVE LANDSCAPE
    • 16.1.1. Company Shares, By Revenue

17 COMPANY PROFILED

  • 17.1. Medtronic
  • 17.2. Becton, Dickinson and Company
  • 17.3. Novo Nordisk
  • 17.4. Eli Lilly and Company
  • 17.5. Sanofi
  • 17.6. Insulet Corporation
  • 17.7. Ypsomed Holding AG
  • 17.8. Tandem Diabetes Care, Inc.
  • 17.9. Animas Corporation
  • 17.10. Biocon Ltd.

18 DISCLAIMER